
Partner
Hospital administrators use its platform to choose which advanced therapies to offer and when to begin months-long preparation for them.
Challenge
The platform needs current data on upcoming therapies and what hospitals need to offer them. Public sources lack the custom fields and use inconsistent formats. The team had no analysts or engineers to build the dataset.
Approach
Outcome
Their spec covers late-stage cell and gene therapies facing an FDA decision within 24 months, with sponsor, phase, FDA status, dates, and trials. Six custom columns add what hospitals need to prepare.

No single source holds values like these. Sleuth’s research agents combine evidence from relevant documents, including paid sources, into each value. The dataset includes the reasoning and sources behind it.


Every Wednesday, a new release lands in their platform. Before it ships, it runs through checks Sleuth wrote from their spec at the start, on top of the knowledge graph’s own. Four of the problems they catch:

When hospitals asked which nearby centers ran each trial, Sleuth added trial-site data to the next release. Brand names followed.
Their hospitals see what’s coming every week, and no one on their team builds or maintains the data.